Skip to content

Assessment of the Tolerability of Dry Airflow in the Nasal Cavity During Sleep

Assessment of the Tolerability of Dry Airflow in the Nasal Cavity During Sleep

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02547688
Enrollment
0
Registered
2015-09-11
Start date
2015-01-31
Completion date
2018-01-31
Last updated
2017-08-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Adults

Brief summary

Preliminary data show that high flow nasal air has been shown to reduce promote heat exchange due to evaporation of nasal mucus by the air flow resulting in heat loss. It is unclear whether unidirectional nasal airflow is well tolerated in healthy individuals. The central hypothesis of this proposal is that dry high flow nasal air will be sufficiently tolerated in healthy adults.

Interventions

Sponsors

Johns Hopkins University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy men and women * Able to consent * Age ≥ 18 * BMI\<30kg/m2

Exclusion criteria

* Previous diagnosis of obstructive sleep apnea or sleep disorder * History of Constant Positive Airway Pressure treatment for Obstructive Sleep Apnea * History of recurrent epistasis * Pregnancy (self-report) * Deviated nasal septum * Unstable cardiovascular disease (decompensated Congestive Heart Failure, myocardial infarction or revascularization procedures, unstable arrhythmias) * Uncontrolled hypertension with BP \> 190/110 * Daytime hypoxemia with oxygen saturation\<90% (measured at history and physical examination) * Supplemental oxygen use * Work in transportation industry as a driver or pilot.

Design outcomes

Primary

MeasureTime frameDescription
Subjective Tolerability using QuestionnaireBaselineParticipant response to nasal high flow using 7 point Likert scale

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026